期刊文献+

固相微萃取膜技术提取水样和尿样中氯氮平

Extraction of clozapine in water and urine by solid-phase microextraction membrane technology
原文传递
导出
摘要 目的:研究固相微萃取膜萃取条件对氯氮平提取效果的影响,建立固相微萃取膜技术提取氯氮平方法。方法:通过改变固相微萃取膜的膜浸泡吸附时间,酸性条件,超声时间,样品种类和浓度等,比较样品中氯氮平提取效果,选择最佳萃取条件,气相色谱法分析水样和尿样中氯氮平含量。结果:通过适当加大样品浓度、延长吸附时间,调节样品pH值为7,将超声技术引用到水样和尿样中膜解析过程,可有效提高固相微萃取膜对样品中氯氮平的提取率。结论:建立的水样和尿样中氯氮平的固相微萃取膜萃取方法,过程简单、检材及耗材用量少、提取率较高,杂质干扰少,可用于液体样品中氯氮平的提取。 Objective:To study the extraction efficiency of clozapine in water and urine by changing the extraction condition and establish a method of using solid-phase micro extraction membrane technology to extract clozapine.Methods: The extraction efficiency of clozapine in water and urine was analyzed by changing the extraction condition of solid-phase micro extraction membrane,such as the membrane adsorption time,acidity,supersonic time,sample type and concentration.Clozapine in water and urine were analyzed using GC.Results: The extraction efficiency of solid-phase micro extraction membrane technology for clozapine in water and urine were higher when sample solution pH was seven and clozapine concentration and immersion time of membrane increased,and the supersonic technology was used to resolve clozapine from membrane.Conclusion: The solid-phase micro extraction membrane method for clozapine in water and urine is simple with less sampling volume and impurity interference and higher extraction efficiency.It can be used for the determination of clozapine in liquid samples.
出处 《中国卫生检验杂志》 北大核心 2012年第11期2667-2669,共3页 Chinese Journal of Health Laboratory Technology
基金 山西省科技攻关项目(20110321082) "十一五"国家科技支撑计划项目(2007BAK26B05)
关键词 氯氮平 固相微萃取膜 气相色谱法 Clozapine Solid-phase micro extraction membrane GC
  • 相关文献

参考文献5

二级参考文献17

  • 1周志凌,程泽能,李坤艳,谢志红,王峰,朱荣华,李焕德.HPLC-MS/ESI法同时检测血浆中4种非典型抗精神病药物[J].中南药学,2004,2(4):205-208. 被引量:13
  • 2关心,陈笑艳,李小燕,张逸凡,孔璋,钟大放.液相色谱-串联质谱法测定人血浆中的米氮平及在药动学中的应用[J].中国新药与临床杂志,2006,25(1):47-51. 被引量:6
  • 3罗芳,刘颖.氯氮平的GC/MS/MS检验[J].刑事技术,2006,31(2):24-26. 被引量:7
  • 4贺佳丽,蔡焯基.氯氮平中毒的临床特征和血液灌流疗效的研究[J].中国神经精神疾病杂志,2007,33(4):250-252. 被引量:28
  • 5van Leeuwen SM, Blankert B, Kauffmann JM, et al. Prediction of clozapine metabolism by on-line electrochemistry/liquid chromatography/mass spectrometry[J]. Anal Bioanal Chem, 2005,382 (3) : 742-750.
  • 6Hong X, Yao Y, Hong S, et al. LC-MS-MS analysis of mirtazapine in plasma, and determination of pharmacokinetic data for rats[J]. Chromatographia,2008,68 (1- 2) : 65-70.
  • 7Aravagiri M, Marder SR. Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients[J]. J Pharm Biomed Anal, 2001,26 (2) : 301-311.
  • 8Niederlander HA, Koster EH, Hilhorst MJ, et al. High throughput therapeutic drug monitoring of clozapine and metabolites in serum by on-line coupling of solid phase extraction with liquid chromatographymass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2006,834(1-2):98-107.
  • 9Nirogi RV, Kandikere VN, Shukla M, et al. Development and validation of a sensitive liquid chromatography/electrospray tandem mass spectrometry assay for the quantification of olanzapine in human plasma[J]. J Pharm Biomed Anal, 2006,41 (3) : 935-942.
  • 10[1]Stevenson R, Amer. Lab., 1993, 25 (9): 24H

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部